GL1X · GenesisL1 explorer

Research workbench

Crystal structure of C-cbl-tkb domain complexed with its binding motif in SPROUTY4

Analyse Crystal structure of C-cbl-tkb domain complexed with its binding motif in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3BUN
Type
protein
Length
311 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
13-meric peptide from protein sprouty homolog 4; E3 ubiquitin-protein ligase cbl
EC
6.3.2.-
UniProt
Q9C004, P22681
Pockets
2 · best druggability 0.47

Structure

x-ray diffraction · 2 distinct chains · 57% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A13-meric peptide from protein sprouty homolog 4protein70% helix, 14% strandQ9C004
BE3 ubiquitin-protein ligase cbl (EC 6.3.2.-)protein30459% helix, 8% strandP22681

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11010.470.8021empty
2570.420.8215empty

Interfaces

1 interface between chains.

  • A–B · 564 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 3BUN · Crystal structure of c-Cbl-TKB domain complexed with its binding motif in Sprouty4 · the same entry in another collection · chain A against A, TM-score 1.00
  • P22681 · AlphaFold monomer V2.0 prediction for E3 ubiquitin-protein ligase cbl (P22681) · a predicted model of the same protein · chain B against A, TM-score 0.98
  • Q9C004 · AlphaFold monomer V2.0 prediction for protein sprouty homolog 4 (Q9C004) · a predicted model of the same protein · chain A against A, TM-score 0.64

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.